AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (3.8 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Integrative pan-cancer analysis identifies CCHCR1 as a prognostic biomarker and therapeutic target driving EMT in hepatocellular carcinoma via PI3K/AKT activation

Shuting Huanga,dWanqiu Lia,dKaifang Wanga,bYu CaiaLirui QiancYiran LiucFeng GaocTong FangaKin Yip Tamb( )Ou Shaa( )
School of Basic Medical Sciences, Shenzhen University Medical School, Shenzhen, Guangdong 518000, China
Faculty of Health Sciences, University of Macau, Taipa, Macau SAR 999078, China
School of Dentistry, Shenzhen University Medical School, Shenzhen, Guangdong 518000, China

d These authors contributed equally to this work.

Peer review under the responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Huang S, Li W, Wang K, et al. Integrative pan-cancer analysis identifies CCHCR1 as a prognostic biomarker and therapeutic target driving EMT in hepatocellular carcinoma via PI3K/AKT activation. Genes & Diseases, 2026, 13(5). https://doi.org/10.1016/j.gendis.2025.101960

8

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 05 August 2025
Published: 28 November 2025
© 2025 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).